Freenome

Freenome

Biotechnology, 259 E Grand Ave Ste 3434, South San Francisco, California, 94080, United States, 201-500 Employees

freenome.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 83********

Who is FREENOME

Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is d...

Read More

map
  • 259 E Grand Ave Ste 3434, South San Francisco, California, 94080, United States Headquarters: 259 E Grand Ave Ste 3434, South San Francisco, California, 94080, United States
  • 2014 Date Founded: 2014
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2835 | NAICS Code: 541720 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from FREENOME

Freenome Org Chart and Mapping

Employees

Alexander Tseng

Senior Computational Research Associate

Yifan Ma

Senior Data Analyst

Derek Hibbs

Technical Lead - Scientific Operations

Giuseppe La Tona

Senior Engineering Manager

Evan Izzo

Clinical Laboratory Associate

Neil Gako

Clinical Laboratory Supervisor- Ngs

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Freenome

Answer: Freenome's headquarters are located at 259 E Grand Ave Ste 3434, South San Francisco, California, 94080, United States

Answer: Freenome's phone number is 83********

Answer: Freenome's official website is https://freenome.com

Answer: Freenome's revenue is $1 Million to $5 Million

Answer: Freenome's SIC: 2835

Answer: Freenome's NAICS: 541720

Answer: Freenome has 201-500 employees

Answer: Freenome is in Biotechnology

Answer: Freenome contact info: Phone number: 83******** Website: https://freenome.com

Answer: Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Societys BrightEdge Ventures. A Freenomer is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access